Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA in Prevention of Ovarian Cancer in Women With BRCA 1/2 Mutations
NCT03480776Phase 2Active, not recruiting
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jul 2018
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of aspirin in ovarian cancer, sponsored by Canadian Cancer Trials Group. Started Jul 2018; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03480776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03480776.